GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

zaloblideg   Click here for help

GtoPdb Ligand ID: 13460

Synonyms: ARV-393 | ARV393 | compound 81 [WO2022221673A1]
Compound class: Synthetic organic
Comment: ARV-393 is an orally active PROTAC that promotes degradation of the BCL6 transcription repressor protein. A lenalidomide derived moiety promotes formation of a ternary complex of the PROTAC, target protein and the E3 ligase cereblon to induce ubiquitination and degradation. The structure shown here has (1r,3r) configuration around the cyclobutoxy group, as indicated for compound 81 in Arvinas' patent WO2022221673A [1]. We will update this entry whenever ARV-393's chemical structure is formally disclosed.
BCL6 is a transcriptional repressor and major driver of B-cell lymphomas. Reducing BCL6 activity or abundance are proposed as mechanisms to treat advanced B-cell malignancies such as non-Hodgkin's lymphoma.
In July 2025 we were able to match the structure of ARV-393 to the INN zaloblideg that was included in WHO INN proposed list 133.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 16
Hydrogen bond donors 3
Rotatable bonds 13
Topological polar surface area 177.58
Molecular weight 898.42
XLogP 1.33
No. Lipinski's rules broken 3

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)N1C2=C(C=C(C=C2)NC3=C(C=NC(=N3)N4CCC(CC4)O[C@H]5C[C@@H](C5)N6CCC(CC6)C7=CC=C8C(=C7F)CN(C9CCC(=O)NC9=O)C8=O)Cl)C=C(C1=O)OCC(=O)NC
Isomeric SMILES CNC(=O)COC1=CC2=C(C=CC(NC3=C(Cl)C=NC(=N3)N4CCC(CC4)O[C@H]5C[C@@H](C5)N6CCC(CC6)C7=CC=C8C(=O)N(CC8=C7F)C9CCC(=O)NC9=O)=C2)N(C(C)C)C1=O
InChI InChI=1S/C46H53ClFN9O7/c1-25(2)57-36-7-4-28(18-27(36)19-38(45(57)62)63-24-40(59)49-3)51-42-35(47)22-50-46(53-42)55-16-12-30(13-17-55)64-31-20-29(21-31)54-14-10-26(11-15-54)32-5-6-33-34(41(32)48)23-56(44(33)61)37-8-9-39(58)52-43(37)60/h4-7,18-19,22,25-26,29-31,37H,8-17,20-21,23-24H2,1-3H3,(H,49,59)(H,50,51,53)(H,52,58,60)/t29-,31-,37?
InChI Key ZOGOEUHUEFKKTD-VVDHFOCHSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

Classification Click here for help
Compound class Synthetic organic
Ligand families/groups PROTACs, molecular glues and other degraders
International Nonproprietary Names Click here for help
INN number INN
13762 zaloblideg
Synonyms Click here for help
ARV-393 | ARV393 | compound 81 [WO2022221673A1]
Database Links Click here for help
CAS Registry No. 2851885-95-3 (source: WHO INN record)
GtoPdb PubChem SID 500839870
PubChem CID 166077922
Search Google for chemical match using the InChIKey ZOGOEUHUEFKKTD-VVDHFOCHSA-N
Search Google for chemicals with the same backbone ZOGOEUHUEFKKTD
Search PubMed clinical trials zaloblideg
Search PubMed titles zaloblideg
Search PubMed titles/abstracts zaloblideg
UniChem Compound Search for chemical match using the InChIKey ZOGOEUHUEFKKTD-VVDHFOCHSA-N
UniChem Connectivity Search for chemical match using the InChIKey ZOGOEUHUEFKKTD-VVDHFOCHSA-N

Product suppliers

View disclaimer

MedChemExpress
ARV-393 (links to external site)
Cat. No. HY-158105